{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:52:16Z","timestamp":1760575936069,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[1999,10]]},"DOI":"10.1053\/clon.1999.9079","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:54:50Z","timestamp":1032429290000},"page":"352-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Superior Vena Cava Obstruction in Prostate Cancer"],"prefix":"10.1053","volume":"11","author":[{"given":"S.E.","family":"Old","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/clon.1999.9079_RF1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0936-6555(05)80445-5","article-title":"Superior vena cava obstruction: a modern management strategy","volume":"9","author":"Ostler","year":"1997","journal-title":"Clin Oncol"},{"key":"10.1053\/clon.1999.9079_RF2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000019546","article-title":"Maximal androgen blockade: final analysis of EORTC Phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center","volume":"33","author":"Denis","year":"1998","journal-title":"Eur Urol"},{"key":"10.1053\/clon.1999.9079_RF3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/sj.pcan.4500265","article-title":"Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: a meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide","volume":"2","author":"Bennett","year":"1999","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1053\/clon.1999.9079_RF4","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1200\/JCO.1993.11.8.1566","article-title":"Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer","volume":"11","author":"Scher","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/clon.1999.9079_RF5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/00365599709070324","article-title":"Treatment of high-grade, high-stage prostate cancer with estramustine phosphate or diethylstilboestrol: a double blind study. The SPCG-1 Study Group","volume":"31","author":"Hedlund","year":"1997","journal-title":"Scand J Urol Nephrol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655599990799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655599990799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:22:41Z","timestamp":1760541761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655599990799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["S0936655599990799"],"URL":"https:\/\/doi.org\/10.1053\/clon.1999.9079","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[1999,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Superior Vena Cava Obstruction in Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/clon.1999.9079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}